Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

AI and computational modeling are reducing reliance on animal testing by simulating human biology, improving drug safety and ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...

Amid the usual hustle before a big medical conference or industry trade show, editors are often buried under a flood of news ...

Following the company’s announcement of lackluster results from both its Phase III trials, Novo’s shares dropped nearly 9% pre-market, a significant shift the company hasn’t seen in its shares since ...

Each step in the patient journey, benefit verification, prior authorization, fulfillment, and adherence, creates a potential failure point when systems don’t communicate. In many first-generation ...

Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, continues his conversation about ...

Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Cancerguard, a multi-cancer early detection blood test.

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...